Medication

Do “self-cleaning” elevator buttons really work? AP Illustration/Peter Hamlin
December 03, 2020 - 3:00 am
Do “self-cleaning” elevator buttons really work? Without rigorous independent studies, experts say it’s hard to verify claims of “self-cleaning” or “antiviral" surfaces that have popped up during the pandemic. But they also say you shouldn’t worry too much about how well such features really work...
Read More
FILE - In this Aug. 15, 2019 file photo, marijuana grows at an indoor cannabis farm in Gardena, Calif. On Monday, Nov. 23, 2020, cannabis stocks are flying high this month after voters in four states passed measures clearing the way for sales of marijuana to adults. That alone is projected to boost the market for legal cannabis sales in the U.S. by 20%. (AP Photo/Richard Vogel, File)
December 02, 2020 - 1:31 pm
BERLIN (AP) — The U.N. Commission on Narcotic Drugs voted Wednesday to remove cannabis and cannabis resin from a category of the world's most dangerous drugs, which could impact the global medical marijuana industry. The Vienna-based U.N. agency said in a statement that it had voted 27-25, with one...
Read More
Laboratory technicians test a blood sample for HIV infection at the Reproductive Health and HIV Institute (RHI) in Johannesburg, Thursday, Nov. 26 2020. The successful trials of a new injectable drug that needs to be taken every eight weeks to prevent HIV infection is being lauded on World AIDS Day as a turning point for the fight against a global health threat that's been eclipsed by the coronavirus pandemic. (AP Photo/Denis Farrell)
December 01, 2020 - 5:17 am
JOHANNESBURG (AP) — Health officials are hoping that new, long-acting drugs to help prevent HIV infection will be a turning point for the fight against a global health threat that’s been eclipsed by the coronavirus pandemic. South African President Cyril Ramaphosa highlighted the new drug in a...
Read More
A patient walks on a corridor of the Rouvray psychiatric hospital, in Rouen, western France, Wednesday, Nov. 25, 2020. Lockdowns that France has used to fight the coronavirus have come at considerable cost to mental health. Surveying points to a surge of depression most acute among people without work, in financial hardship and young adults. (AP Photo/Thibault Camus)
December 01, 2020 - 2:54 am
ROUEN, France (AP) — The panicked 22-year-old is led to Consultation Room No. 2, with its easy-mop floor and honeycombed meshing over the window. Behind her, the psychiatric emergency ward's heavy double doors — openable only with a staff member's key — thud shut. With anxious taps of her white...
Read More
European Commissioner for Europe fit for the Digital Age Margrethe Vestager speaks during a media conference on European Data Governance at EU headquarters in Brussels, Wednesday, Nov. 25, 2020. (Stephanie Lecocq, Pool via AP)
November 26, 2020 - 7:32 am
The European Union has fined two pharmaceutical companies for colluding to keep a cheap alternative to a sleep disorder medicine off the market for their profit and at the expense of patients. EU antitrust commissioner, Margrethe Vestager, said that Teva pharmaceuticals and Cephalon, a company it...
Read More
In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, scientists work with a bioreactor at a company facility in New York state, for efforts on an experimental coronavirus antibody drug. The Food and Drug Administration on Saturday, Nov. 21, 2020 authorized the use of the Regeneron Pharmaceuticals Inc. drug to try to prevent patients with mild-to-moderate disease from worsening and needing hospitalization. It's given as a one-time treatment through an IV and is still going through more testing to establish its safety and effectiveness. (Regeneron via AP)
November 21, 2020 - 11:52 pm
U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month. The Food and Drug Administration authorized use of the Regeneron...
Read More
FILE - In this Sept. 22, 2020, file photo Housing and Urban Development Secretary Ben Carson speaks to reporters after touring the Plymouth Place senior housing facility in Des Moines, Iowa. Carson is crediting unapproved, experimental treatments with saving his life after saying he became “desperately ill” following his infection with the coronavirus. There is no medical evidence that the treatments Carson cites in a statement on his personal Facebook page worked. (AP Photo/Charlie Neibergall, File)
November 21, 2020 - 1:33 pm
STERLING, Va. (AP) — Housing Secretary Ben Carson is crediting unapproved, experimental treatments with saving his life after he became “desperately ill” following his infection with the coronavirus. There is no medical evidence that the treatments Carson cited worked. A retired neurosurgeon,...
Read More
In this Feb. 12, 2019 photo, Meghan Waldron walks down the street in Boston. Waldron is a student at Emerson College with progeria, one of the world's rarest diseases. The first treatment has been approved for progeria, Friday, Nov. 20, 2020. The U.S. Food and Drug Administration on Friday approved Zokinvy which was shown in testing to extend patients’ lives by 2 ½ years on average. (Suzanne Kreiter/The Boston Globe via AP)
November 20, 2020 - 7:06 pm
The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives. Kids with the genetic disorder progeria typically die in their early teens, usually from heart disease. But in testing, children...
Read More
President Donald Trump speaks during a news conference in the briefing room at the White House in Washington, Friday, Nov. 20, 2020. (AP Photo/Susan Walsh)
November 20, 2020 - 2:59 pm
WASHINGTON (AP) — Trying to close out major unfinished business, the Trump administration issued regulations Friday that could lower the prices Americans pay for many prescription drugs. But in a time of political uncertainty, it’s hard to say whether the rules will withstand expected legal...
Read More
FILE - In this Thursday Oct. 15, 2020 file photo, A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary. Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. The World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines. (Zsolt Czegledi/MTI via AP, File)
November 20, 2020 - 12:38 am
Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. On Friday, a World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized...
Read More

Pages